BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 32333272)

  • 1. Susceptibility and resistance of Sporothrix brasiliensis to branded and compounded itraconazole formulations.
    Waller SB; Ripoll MK; Madrid IM; Acunha T; Cleff MB; Chaves FC; de Mello JRB; de Faria RO; Meireles MCA
    Braz J Microbiol; 2021 Mar; 52(1):155-162. PubMed ID: 32333272
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Refractory sporotrichosis due to Sporothrix brasiliensis in humans appears to be unrelated to in vivo resistance.
    Almeida-Paes R; Oliveira MME; Freitas DFS; Valle ACFD; Gutierrez-Galhardo MC; Zancopé-Oliveira RM
    Med Mycol; 2017 Jul; 55(5):507-517. PubMed ID: 27771622
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chemical and cytotoxic analyses of brown Brazilian propolis (Apis mellifera) and its in vitro activity against itraconazole-resistant Sporothrix brasiliensis.
    Waller SB; Peter CM; Hoffmann JF; Picoli T; Osório LD; Chaves F; Zani JL; de Faria RO; de Mello JR; Meireles MC
    Microb Pathog; 2017 Apr; 105():117-121. PubMed ID: 28219829
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Feline sporotrichosis: a case series of itraconazole-resistant Sporothrix brasiliensis infection.
    Nakasu CCT; Waller SB; Ripoll MK; Ferreira MRA; Conceição FR; Gomes ADR; Osório LDG; de Faria RO; Cleff MB
    Braz J Microbiol; 2021 Mar; 52(1):163-171. PubMed ID: 32388779
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Benzylidene-carbonyl compounds are active against itraconazole-susceptible and itraconazole-resistant Sporothrix brasiliensis.
    Waller SB; Cleff MB; Ripoll MK; Meireles MCA; Varela MT; Fernandes JPDS
    Folia Microbiol (Praha); 2020 Dec; 65(6):1033-1038. PubMed ID: 32821987
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antifungal activity of diphenyl diselenide alone and in combination with itraconazole against Sporothrix brasiliensis.
    Poester VR; Mattei AS; Mendes JF; Klafke GB; Ramis IB; Sanchotene KO; Xavier MO
    Med Mycol; 2019 Apr; 57(3):328-331. PubMed ID: 29924365
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Miltefosine is active against Sporothrix brasiliensis isolates with in vitro low susceptibility to amphotericin B or itraconazole.
    Borba-Santos LP; Gagini T; Ishida K; de Souza W; Rozental S
    J Med Microbiol; 2015 Apr; 64(Pt 4):415-422. PubMed ID: 25681323
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clotrimazole is highly effective in vitro against feline Sporothrix brasiliensis isolates.
    Gagini T; Borba-Santos LP; Messias Rodrigues A; Pires de Camargo Z; Rozental S
    J Med Microbiol; 2017 Nov; 66(11):1573-1580. PubMed ID: 28984226
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular Identification and Antifungal Susceptibility of Clinical Isolates of Sporothrix schenckii Complex in Medellin, Colombia.
    Flórez-Muñoz SV; Alzate JF; Mesa-Arango AC
    Mycopathologia; 2019 Feb; 184(1):53-63. PubMed ID: 30554299
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Canine sporotrichosis: polyphasic taxonomy and antifungal susceptibility profiles of Sporothrix species in an endemic area in Brazil.
    Boechat JS; Pereira SA; de Sá Machado AC; Viana PG; Almeida-Paes R; Zancopé-Oliveira RM; Gremião IDF; de Oliveira MME
    Braz J Microbiol; 2021 Mar; 52(1):135-143. PubMed ID: 32617836
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro susceptibility of antifungal drugs against Sporothrix brasiliensis recovered from cats with sporotrichosis in Brazil.
    Brilhante RS; Rodrigues AM; Sidrim JJ; Rocha MF; Pereira SA; Gremião ID; Schubach TM; de Camargo ZP
    Med Mycol; 2016 Mar; 54(3):275-9. PubMed ID: 26591009
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sporotrichosis Caused by Non-Wild Type
    Bernardes-Engemann AR; Tomki GF; Rabello VBS; Almeida-Silva F; Freitas DFS; Gutierrez-Galhardo MC; Almeida-Paes R; Zancopé-Oliveira RM
    Front Cell Infect Microbiol; 2022; 12():893501. PubMed ID: 35694546
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bioisosteric modification on benzylidene-carbonyl compounds improved the drug-likeness and maintained the antifungal activity against Sporothrix brasiliensis.
    Waller SB; Cleff MB; Ripoll MK; Meireles MCA; Ferrarini M; Varela MT; Fernandes JPS
    Chem Biol Drug Des; 2022 Mar; 99(3):391-397. PubMed ID: 34873847
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Atypical Clinical Presentation of Sporotrichosis Caused by Sporothrix globosa Resistant to Itraconazole.
    Fischman Gompertz O; Rodrigues AM; Fernandes GF; Bentubo HD; de Camargo ZP; Petri V
    Am J Trop Med Hyg; 2016 Jun; 94(6):1218-22. PubMed ID: 27114300
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antifungal resistance on Sporothrix species: an overview.
    Waller SB; Dalla Lana DF; Quatrin PM; Ferreira MRA; Fuentefria AM; Mezzari A
    Braz J Microbiol; 2021 Mar; 52(1):73-80. PubMed ID: 32476087
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro activity of the anthelmintic drug niclosamide against Sporothrix spp. strains with distinct genetic and antifungal susceptibility backgrounds.
    Ramos MLM; Almeida-Silva F; de Souza Rabello VB; Nahal J; Figueiredo-Carvalho MHG; Bernardes-Engemann AR; Poester VR; Xavier MO; Meyer W; Zancopé-Oliveira RM; Frases S; Almeida-Paes R
    Braz J Microbiol; 2024 Jun; 55(2):1359-1368. PubMed ID: 38466550
    [TBL] [Abstract][Full Text] [Related]  

  • 17.
    Almeida-Silva F; Coelho RA; Bernardes-Engemann AR; Fichman V; Freitas DF; Galhardo MC; Corrêa-Junior D; Frases S; Zancopé-Oliveira RM; Almeida-Paes R
    Future Microbiol; 2023 Nov; 18():1041-1048. PubMed ID: 37721514
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Susceptibility of Sporothrix brasiliensis isolates to amphotericin B, azoles, and terbinafine.
    Borba-Santos LP; Rodrigues AM; Gagini TB; Fernandes GF; Castro R; de Camargo ZP; Nucci M; Lopes-Bezerra LM; Ishida K; Rozental S
    Med Mycol; 2015 Feb; 53(2):178-88. PubMed ID: 25394542
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro susceptibility of Sporothrix brasiliensis: Comparison of yeast and mycelial phases.
    Sanchotene KO; Brandolt TM; Klafke GB; Poester VR; Xavier MO
    Med Mycol; 2017 Nov; 55(8):869-876. PubMed ID: 28472490
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Potential use of Nikkomycin Z as an anti- Sporothrix spp. drug.
    Poester VR; Munhoz LS; Larwood D; Martinez M; Stevens DA; Xavier MO
    Med Mycol; 2021 Apr; 59(4):345-349. PubMed ID: 32634218
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.